Upgrade Now

Company Announcements

Issue of Equity

Related Companies

RNS Number : 1454M
Avacta Group PLC
05 May 2015
 

 

 

Press Release

5 May 2015

 

Avacta Group plc

("Avacta" or the "Group")

 

Issue of Equity

 

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that 3,850,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by former employees.

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 8 May 2015.

 

The total number of Ordinary Shares in issue following the above issue will be 4,979,149,550 each with voting rights.  No Ordinary Shares are held in Treasury.

 

The above figure of 4,979,149,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

 

 

- Ends -

 

Enquiries:

Avacta Group plc

Tel:  +44 (0) 844 414 0452

Alastair Smith, Chief Executive Officer

www.avacta.com

Tim Sykes, Chief Financial Officer




Numis Securities Limited

Tel:  +44 (0) 207 260 1000

Michael Meade / Freddie Barnfield - Nominated Adviser

www.numiscorp.com

James Black - Corporate Broking




Walbrook PR Limited

                     Tel: +44 (0) 20 7933 8780 or 

                        avacta@walbrookpr.com

Paul McManus

                       Mob: +44 (0)7890 541 893

Lianne Cawthorne

                       Mob: +44 (0)7584 391 303

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:

 

Avacta Animal Health

www.avactaanimalhealth.com

Veterinary diagnostics reference laboratory and diagnostic kit provider.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUSVNRVKAVRAR

Top of Page